Skip to content

Propofol for Anesthesia

Comparison of different doses of propofol for laryngeal mask airway insertion in children

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT201101304041N3
Enrollment
120
Registered
2011-04-16
Start date
2010-12-22
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: Pediatric Anesthesia. Condition 2: pediatric anesthesia. Condition 3: pediatric anesthesia. Unilateral or unspecified inguinal hernia, without obstruction or gangrene Bilateral inguinal hernia, without obstruction or gangrene Other congenital malformations of digestive system

Interventions

Intervention 1: first group: propofol 2.5mg/kg for LMA insertion. Intervention 2: second group: propofol 3.5mg/kg for LMA insertion.
Prevention
first group: propofol 2.5mg/kg for LMA insertion
second group: propofol 3.5mg/kg for LMA insertion

Sponsors

Vice chancellor for research, Tabriz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 7 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: children with ASA class I ? II; candidated for lower abdominal surgeries, hernioraphy and so on; below 20 kg. Exclusion criteria: children with airway anomalies, hitory of upper respiratory infection in past 4 weeks.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
LMA insertion complication: cough, swallowing, larungospasm. Timepoint: once. Method of measurement: observation.

Secondary

MeasureTime frame
Ease of LMA insertion. Timepoint: once, after insertion of LMA. Method of measurement: ease of ventilation (normal wave of capnography & no airway leakage after LMA insertion).

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr.Mahin Seyedhejazi

Tabriz University of Medical Sciences

seidhejazie@yahoo.com , seidhejazie@tbzmed.ac.ir+98 41 1526 2250

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026